| Answer | The E2/E2 combination of ApoE isoforms is considered lower risk with a 0.6 odds ratio for the development of Alzheimer's disease versus the most common combination of ApoE isoforms (E3/E3). | LA32571-4 |
| Answer | The E2/E3 combination of ApoE isoforms is considered lower risk with a 0.6 odds ratio for the development of Alzheimer's disease versus the most common combination of ApoE isoforms (E3/E3). | LA32572-2 |
| Answer | The E3/E3 combination of ApoE isoforms is the most common and is considered average risk with a 1.0 odds ratio for the development of Alzheimer's disease. | LA32573-0 |
| Answer | The E2/E4 combination of ApoE isoforms is considered higher risk with a 2.6 odds ratio for the development of Alzheimer's disease versus the most common combination of ApoE isoforms (E3/E3). | LA32574-8 |
| Answer | The E3/E4 combination of ApoE isoforms is considered higher risk with a 3.2 odds ratio for the development of Alzheimer's disease versus the most common combination of ApoE isoforms (E3/E3). | LA32575-5 |
| Answer | The E4/E4 combination of ApoE isoforms is considered high risk with a 14.9 odds ratio for the development of Alzheimer's disease versus the most common combination of ApoE isoforms (E3/E3). | LA32576-3 |
| answers-for | Apolipoprotein E phenotype [Interpretation] in Cerebral spinal fluid Narrative | 98484-9 |
| LONG_COMMON_NAME | en-US | APOE Interpretations |
LOINC Version: 2.77
FHIR